ASPARAGINASE Side Effects

6919502-9 | Liver Function Test Abnormal, Liver Injury
on Aug 10, 2010 Female patient from UNITED STATES , 58 years of age, was treated with Asparaginase (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal, liver injury. Asparaginase dosage: 9600 Iu Iv (10/2, 10/4, 10/6 And 10/9/08). During the same period patient was treated with ONCOVIN (2 Mg Iv Q Weekly (9/30, 10/7 And 10/13/08)) (View Oncovin Review and Oncovin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6290580-6 | Asthenia, Cholestasis, Decreased Appetite, Fatigue, Full Blood Count Abnormal, Hepatic Steatosis, Hepatotoxicity, Hypocoagulable State, Leukaemic Infiltration Hepatic
Patient was taking Asparaginase (View Usage). Patient had the following side effects: asthenia, cholestasis, decreased appetite, fatigue, full blood count abnormal, hepatic steatosis, hepatotoxicity, hypocoagulable state, leukaemic infiltration hepatic on Jul 28, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Asparaginase dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6290580-6 | Asthenia, Cholestasis, Decreased Appetite, Fatigue, Full Blood Count Abnormal, Hepatic Steatosis, Hepatotoxicity, Hypocoagulable State, Leukaemic Infiltration Hepatic
Adverse event was reported on Jul 28, 2009 by a Female patient taking Asparaginase (View Usage) (Dosage: ) . Location: UNITED STATES , 56 years of age, After Asparaginase was administered, patient had the following side effects: asthenia, cholestasis, decreased appetite, fatigue, full blood count abnormal, hepatic steatosis, hepatotoxicity, hypocoagulable state, leukaemic infiltration hepatic. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6177452-2 | Ataxia, Dysarthria, Fall, Influenza Like Illness
on May 01, 2009 Male patient from UNITED STATES , 58 years of age, weighting 191.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Asparaginase (View Usage). Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), dysarthria, fall (What is fall?), influenza like illness. Asparaginase dosage: 20,000 Units Im Q Wk. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.


5211891-9 | Myalgia, Pyrexia
on Jan 16, 2007 Male patient from UNITED STATES , 21 years of age, was treated with Asparaginase (View Usage). Patient had the following side effects: myalgia, pyrexia. Asparaginase dosage: . During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ). Patient was hospitalized.

5158302-X | Hyperglycaemia, Hyperosmolar State
Patient was taking Asparaginase (View Usage). After Asparaginase was administered, patient had the following side effects: hyperglycaemia, hyperosmolar state on Nov 21, 2006 from UNITED STATES Additional patient health information: Male patient , 62 years of age, . Asparaginase dosage: 20,000 Units Daily Times 7 Days Iv. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

4708336-1 | Pruritus, Rash Macular
Adverse event was reported on Jul 05, 2005 by a Female patient taking Asparaginase (View Usage) (Dosage: ) . Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: pruritus, rash macular. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), TYLENOL (View Tylenol Review and Tylenol Label ).